The demand for Anti-Diabetes Drugs in Qatar has been increasing steadily over the years.
Customer preferences: Patients in Qatar are increasingly preferring Anti-Diabetes Drugs due to the high prevalence of diabetes in the country. According to a report by the International Diabetes Federation, Qatar has one of the highest rates of diabetes in the world, with over 16% of the population suffering from the disease. This has led to a rise in demand for Anti-Diabetes Drugs as a means of managing the condition.
Trends in the market: The Anti-Diabetes Drugs market in Qatar has witnessed a shift towards newer, more advanced drugs. This is due to the increasing awareness among patients about the benefits of these drugs, as well as the availability of newer drugs in the market. In addition, there has been a rise in demand for combination drugs that offer multiple benefits in a single pill. This trend is expected to continue in the coming years, as patients become more informed about the benefits of these drugs.
Local special circumstances: One of the key factors driving the Anti-Diabetes Drugs market in Qatar is the high prevalence of diabetes in the country. This has led to a rise in demand for these drugs, as patients seek to manage their condition and improve their quality of life. In addition, the government has been taking steps to promote the use of Anti-Diabetes Drugs, such as by providing subsidies for certain drugs and increasing public awareness about the disease.
Underlying macroeconomic factors: The Anti-Diabetes Drugs market in Qatar is also influenced by broader macroeconomic factors, such as the country's economic growth and healthcare spending. Qatar has been experiencing strong economic growth in recent years, which has led to an increase in healthcare spending. This, in turn, has led to a rise in demand for Anti-Diabetes Drugs and other healthcare products. In addition, the government's focus on improving healthcare infrastructure and services has also contributed to the growth of the Anti-Diabetes Drugs market in Qatar.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
